{
    "organizations": [],
    "uuid": "5e4fe32fec10de91e7193a181e8f6694a76054f9",
    "author": "",
    "url": "https://www.reuters.com/article/brief-chromadex-patent-trial-and-appeal/brief-chromadex-patent-trial-and-appeal-board-of-u-s-patent-and-trademark-office-denied-elysium-healths-request-to-invalidate-u-s-patent-idUSFWN1PH0MF",
    "ord_in_thread": 0,
    "title": "BRIEF-Chromadex - Patent Trial And Appeal Board Of U.S. Patent And Trademark Office Denied Elysium Health's Request To Invalidate U.S. Patent",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "#Market News January 22, 2018 / 11:45 AM / in 9 hours BRIEF-Chromadex - Patent Trial And Appeal Board Of U.S. Patent And Trademark Office Denied Elysium Health's Request To Invalidate U.S. Patent Reuters Staff 1 Min Read \nJan 22 (Reuters) - Chromadex Corp: \n* CHROMADEX - PATENT TRIAL AND APPEAL BOARD OF U.S. PATENT AND TRADEMARK OFFICE DENIED ELYSIUM HEALTH INC.â€˜S REQUEST TO INVALIDATE U.S. PATENT \n* CHROMADEX - U.S. PATENT COVERING COMPOSITIONS COMPRISING NICOTINAMIDE RIBOSIDE, WHICH CHROMADEX CURRENTLY LICENSES FROM TRUSTEES OF DARTMOUTH COLLEGE Source text for Eikon: Further company coverage:",
    "published": "2018-01-22T13:43:00.000+02:00",
    "crawled": "2018-01-22T14:04:53.014+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "market",
        "news",
        "january",
        "hour",
        "patent",
        "trial",
        "appeal",
        "board",
        "patent",
        "trademark",
        "office",
        "denied",
        "elysium",
        "health",
        "request",
        "invalidate",
        "patent",
        "reuters",
        "staff",
        "min",
        "read",
        "jan",
        "reuters",
        "chromadex",
        "corp",
        "chromadex",
        "patent",
        "trial",
        "appeal",
        "board",
        "patent",
        "trademark",
        "office",
        "denied",
        "elysium",
        "health",
        "request",
        "invalidate",
        "patent",
        "chromadex",
        "patent",
        "covering",
        "composition",
        "comprising",
        "nicotinamide",
        "riboside",
        "chromadex",
        "currently",
        "license",
        "trustee",
        "dartmouth",
        "college",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}